» Authors » K Marcus

K Marcus

Explore the profile of K Marcus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 561
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Unterberg M, Ehrentraut S, Bracht T, Wolf A, Haberl H, von Busch A, et al.
Crit Care . 2023 Nov; 27(1):417. PMID: 37907989
Background: Sepsis is one of the leading causes of death. Treatment attempts targeting the immune response regularly fail in clinical trials. As HCMV latency can modulate the immune response and...
2.
Marcus K, Balasubramaniam M, Short S, Sohn W
Community Dent Health . 2022 Mar; 39(2):123-128. PMID: 35333480
Objective: To examine the patterns and predictors of dental utilisation in culturally and linguistically diverse (CALD) and non-CALD groups in New South Wales. Design: Secondary analysis of the 2013 and...
3.
Winter L, Unger A, Berwanger C, Sporrer M, Turk M, Chevessier F, et al.
Neuropathol Appl Neurobiol . 2018 Sep; 45(5):476-494. PMID: 30179276
Aims: We investigated newly generated immortalized heterozygous and homozygous R349P desmin knock-in myoblasts in conjunction with the corresponding desminopathy mice as models for desminopathies to analyse major protein quality control...
4.
Liang K, Marcus K, Guo L, Li Z, Zhou L, Li Y, et al.
Chem Commun (Camb) . 2017 Jun; 53(54):7608-7611. PMID: 28639648
An ultrathin, freestanding NiS nanoporous thin-film was developed by facile electrochemical deposition, etching, anodization and chemical vapor treatments. The NiS nanoporous thin-film shows excellent reversible insertion/extraction of Mg ions and...
5.
Maerkens A, Olive M, Schreiner A, Feldkirchner S, Schessl J, Uszkoreit J, et al.
Acta Neuropathol Commun . 2016 Feb; 4:8. PMID: 26842778
Introduction: Myofibrillar myopathies are characterized by progressive muscle weakness and impressive abnormal protein aggregation in muscle fibers. In about 10 % of patients, the disease is caused by mutations in...
6.
Tsiamas P, Mishra P, Cifter F, Berbeco R, Marcus K, Sajo E, et al.
Med Phys . 2014 Feb; 41(2):021701. PMID: 24506592
Purpose: To investigate the potential of low-Z/low-MV (low-Z) linac targets for gold nanoparticle radiotherapy (GNPT) and to determine the microscopic dose enhancement ratio (DER) due to GNP for the alternative...
7.
Plum S, Helling S, Theiss C, Leite R, May C, Jacob-Filho W, et al.
J Proteomics . 2013 Aug; 94:202-206. PMID: 23917253
Biological Significance: Key features of Parkinson's disease are the degeneration of dopaminergic neurons in the substantia nigra pars compacta, an associated loss of the brain pigment neuromelanin and a resulting...
8.
Maerkens A, Kley R, Olive M, Theis V, van der Ven P, Reimann J, et al.
J Proteomics . 2013 May; 90:14-27. PMID: 23639843
Biological Significance: Our proteomic analysis provides essential new insights in the composition of pathological protein aggregates in skeletal muscle fibers of desminopathy patients. The results contribute to a better understanding...
9.
Tsiamas P, Sajo E, Cifter F, Theodorou K, Kappas C, Makrigiorgos M, et al.
Phys Med . 2013 Mar; 30(1):47-56. PMID: 23517668
The aim of this study is twofold: (a) determination of the spectral differences for flattening-filter-free (FFF) versus standard (STD) linac under various clinical conditions, (b) based on an extensive list...
10.
Triant V, Josephson F, Rochester C, Althoff K, Marcus K, Munk R, et al.
Clin Infect Dis . 2011 Nov; 54(3):408-13. PMID: 22095570
Clinical decisions are ideally based on randomized trials but must often rely on observational data analyses, which are less straightforward and more influenced by methodology. The authors, from a series...